Related Experiment Video
Updated: May 8, 2026

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
Published on: April 13, 2018
Stem cell therapy for electrophysiological disorders
Evgeny Pokushalov1, Alexander Romanov, Jonathan S Steinberg
1State Research Institute of Circulation Pathology, 15 Rechkunovskaya St., Novosibirsk, Russia, 630055. E.Pokushalov@gmail.com
Insights
Stem cell therapies show promise for treating cardiovascular diseases by regenerating heart cells. Further research is needed to understand their antiarrhythmic potential and ensure safety before widespread clinical use.
Area of Science:
- Regenerative medicine
- Cardiology
- Stem cell biology
Background:
- Cardiovascular diseases are a primary global cause of death.
- Adult cardiomyocytes have limited regenerative capacity.
- Cell- and gene-based therapies offer novel approaches for myocardial repair.
Purpose of the Study:
- To review stem cell therapy mechanisms for antiarrhythmic treatment.
- To discuss the potential of induced pluripotent stem cell-derived cardiomyocytes.
- To evaluate early clinical results of stem cell-based cardiac therapies.
Main Methods:
- Review of existing literature on stem cell therapies for cardiovascular diseases.
- Analysis of mechanisms underlying stem cell function in myocardial repair.
- Examination of electrophysiological and contractile properties of stem cell-derived cardiomyocytes.
Main Results:
- Stem cell therapies present potential advantages and disadvantages for treating electrophysiological disorders.
- Human induced pluripotent stem cell-derived cardiomyocytes are of significant interest for personalized medicine.
- Understanding stem cell electrophysiology is crucial for therapeutic application.
Conclusions:
- Stem cell therapy is a promising strategy for antiarrhythmic treatment in cardiovascular diseases.
- Further investigation into stem cell function and safety is essential.
- Early clinical data suggests potential but requires more extensive study.
Abstract:
Cardiovascular diseases are a leading cause of mortality worldwide. Terminally differentiated adult cardiomyocytes lack the innate ability to regenerate. Cell- and gene-based therapies are emerging as exciting new experimental strategies for myocardial repair and treatment of a variety of cardiovascular diseases. The potential advantages and shortcomings of each strategy for electrophysiological disorders are discussed. Since the first description of human induced pluripotent stem cell-derived cardiomyocytes, these cells have garnered tremendous interest for their potential use in patient-specific analysis and therapy. However, a full understanding of their electrophysiological and contractile function is necessary before this potential can be realized. This review focuses on the mechanisms by which stem cell therapy may function as an antiarrhythmic treatment and early clinical results.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Stem Cell Culture
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Embryonic Stem Cells

